Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model

Background To limit the use of antimicrobials without disincentivising the development of novel antimicrobials, there is interest in establishing innovative models that fund antimicrobials based on an evaluation of their value as opposed to the volumes used. The aim of this project was to evaluate t...

詳細記述

書誌詳細

主要な著者:	Beth Woods, Laetitia Schmitt, Dina Jankovic, Benjamin Kearns, Alison Scope, Shijie Ren, Tushar Srivastava, Chu Chang Ku, Jean Hamilton, Claire Rothery, Laura Bojke, Mark Sculpher, Sue Harnan
フォーマット:	Artigo
言語:	Inglês
出版事項:	NIHR Journals Library 2024-06-01
シリーズ:	Health Technology Assessment
主題:	cefiderocol colistin drug resistance bacterial antibacterial agents cost–benefit analysis cost-effectiveness analysis quality-adjusted life-years network meta-analysis oxacillinase expert elicitation microbial sensitivity tests systematic review pseudomonas aeruginosa gram-negative bacterial infections beta-lactamases
オンライン･アクセス:	https://doi.org/10.3310/YGWR4511
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!